Heterocyclic compounds with effects against neurodegenerative diseases
Novel, non-peptidic active agents based on aminopyrazoles imitate and bind abnormal b-sheet structures of peptides and proteins characteristic of Alzheimer?s diseases and TSE diseases. TSE diseases are transmissible spongiform encephalopathies.<p>
The novel active agents feature a rigid structure and a characteristic donor-acceptor-donor motive that recognizes abnormal b-sheet structures of peptides and proteins as in the lock-key-principle. For this reason, the formation and aggregation of the b-amyloid plaques, which pervade the patients? cortex and cause the dying off of neurons and a gradual loss of brain function, is inhibited.
Further Information: PDF
TransMIT Gesellschaft für Technologietransfer mbH
Phone: +49 (0)641/943 64-12
Contact
Dr. Peter Stumpf
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Parallel Paths: Understanding Malaria Resistance in Chimpanzees and Humans
The closest relatives of humans adapt genetically to habitats and infections Survival of the Fittest: Genetic Adaptations Uncovered in Chimpanzees Görlitz, 10.01.2025. Chimpanzees have genetic adaptations that help them survive…
You are What You Eat—Stanford Study Links Fiber to Anti-Cancer Gene Modulation
The Fiber Gap: A Growing Concern in American Diets Fiber is well known to be an important part of a healthy diet, yet less than 10% of Americans eat the minimum recommended…
Trust Your Gut—RNA-Protein Discovery for Better Immunity
HIRI researchers uncover control mechanisms of polysaccharide utilization in Bacteroides thetaiotaomicron. Researchers at the Helmholtz Institute for RNA-based Infection Research (HIRI) and the Julius-Maximilians-Universität (JMU) in Würzburg have identified a…